345.2 𩺠åèç
345.2.1 é«é »èé»
345.2.1.1 Pathogens
- E. coli (75-95% uncomplicated)
- S. saprophyticus (5-10% young women)
- Klebsiella, Proteus, Enterococcus
- Pseudomonas (complicated, instrumentation)
- ESBL/CRE increasing
345.2.1.2 Uncomplicated Cystitis Treatment
- Nitrofurantoin 100 BID Ã 5 d (first-line)
- TMP-SMX Ã 3 d (if resistance < 20%)
- Fosfomycin 3 g single dose
- Cephalexin, β-lactams second-line
345.2.1.3 Pyelonephritis Treatment
- Outpatient: ciprofloxacin à 5-7 d
- Inpatient: ceftriaxone, pip-tazo, fluoroquinolone
- Duration: 7-14 d uncomplicated; 14-21 d complicated
345.2.1.4 Asymptomatic Bacteriuria
- Treat ONLY:
- Pregnancy
- Pre-urologic procedure
- Otherwise: donât treat
345.2.1.5 Recurrent UTI Prevention
- Postcoital prophylaxis
- Continuous prophylaxis (TMP-SMX, nitrofurantoin)
- Vaginal estrogen (postmenopausal)
- Methenamine hippurate (ALTAR 2022)
- Cranberry (modest)
- D-mannose
- Vaccines emerging (Uromune)
345.2.1.6 Acute Bacterial Prostatitis
- E. coli, Klebsiella common
- Fluoroquinolone à 4-6 weeks
- Avoid prostatic massage (bacteremia)
345.2.1.8 CP/CPPS
- ⥠3 mo pelvic pain
- No infection
- Multidisciplinary (α-blocker, NSAIDs, PT, antidepressants)
345.2.1.9 MDR UTI Treatment
- ESBL: carbapenems (ertapenem, meropenem)
- CRE: ceftaz-avibactam, meropenem-vaborbactam, imipenem-relebactam, cefiderocol
- MDR Pseudomonas: ceftolozane-tazo, ceftaz-avibactam, cefiderocol
345.2.2 ææ··æ·æ¯èŒ
| Condition | Symptoms | Treatment | Duration |
|---|---|---|---|
| Cystitis | Dysuria, frequency, no fever | Nitrofurantoin, TMP-SMX, fosfomycin | 3-5 d |
| Pyelonephritis | + Fever, flank | Cipro, ceftriaxone, pip-tazo | 7-14 d |
| Complicated UTI | Variable | Broad-spectrum | 7-14 d |
| Acute prostatitis | Pelvic pain + fever | Fluoroquinolone | 4-6 weeks |
| Chronic prostatitis | Recurrent UTIs | Fluoroquinolone | 4-6 weeks |
| CP/CPPS | Chronic pelvic pain | Multimodal | Chronic |
| Asymptomatic bacteriuria | None | Treat only in pregnancy / pre-procedure | N/A |